Average Co-Inventor Count = 7.81
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (15 from 822 patents)
2. Abbvie B.v. (7 from 13 patents)
3. Abbott Laboratories Corporation (2 from 4,179 patents)
4. Abbvie Bahamas Limited (2 from 6 patents)
5. Abbvie Deutschland Gmbh and Co Kg (1 from 167 patents)
6. Abbvie Biotherapeutics Inc. (1 from 51 patents)
7. Abbivie Inc. (1 from 1 patent)
22 patents:
1. 12121589 - Anti-CD19 antibody drug conjugates
2. 11427598 - Spiro-cyclic amine derivatives as S1P modulators
3. RE48301 - Fused heterocyclic derivatives as S1P modulators
4. 10807991 - Spiro-cyclic amine derivatives as S1P modulators
5. 10772970 - Glucocorticoid receptor agonist and immunoconjugates thereof
6. 10668167 - Glucocorticoid receptor agonist and immunoconjugates thereof
7. 10179791 - Spiro-cyclic amine derivatives as S1P modulators
8. 10106501 - Nuclear receptor modulators
9. 9951084 - Spiro-cyclic amine derivatives as S1P modulators
10. 9670220 - Fused heterocyclic derivatives as S1P modulators
11. 9273017 - (Thio)morpholine derivatives as S1P modulators
12. 9163007 - 5-substituted indazoles as kinase inhibitors
13. 9115151 - Substituted 2,10-dihydro-9-oxa-1,2,4A-triazaphenanthren-3-ones and uses thereof
14. 9096612 - Fused heterocyclic derivatives as S1P modulators
15. 9045441 - (Thio)morpholine derivatives as S1P modulators